ICER releases obesity medications white paper examining strategies to ensure affordable access

ICER

9 April 2025 - Paper analyses policy reforms and market actions to achieve affordable and equitable access for GLP-1 obesity medications; developed as part of ICER’s Policy Leadership Forum with input from diverse stakeholders.

The ICER, in collaboration with researchers from Brown University, has published a new white paper today that provides clear policy and market solutions to help manage affordable and equitable access to GLP-1 obesity medications.

Read ICER Announcement

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing